Insulet (MEX:PODD) Accounts Payable: MXN2,701 Mil (As of Mar. 2026)


MEX:PODD Insulet Corp MEX:PODD
75 GF Score
Price MXN2,780.00
GF Value MXN8,194.79
Valuation Significantly Undervalued
View Full Analysis

What is Insulet Accounts Payable?

Insulet MEX:PODD 75 Accounts Payable is MXN2,701 Mil as of Mar. 2026. GuruFocus rates MEX:PODD with a GF Score™ of 75/100 and a GF Value™ of MXN8,194.79 (Significantly Undervalued).

Insulet's Accounts Payable for the quarter that ended in Mar. 2026 was MXN2,701 Mil.

Insulet's quarterly Accounts Payable increased from Sep. 2025 (MXN884 Mil) to Dec. 2025 (MXN1,350 Mil) and increased from Dec. 2025 (MXN1,350 Mil) to Mar. 2026 (MXN2,701 Mil).

Insulet's annual Accounts Payable increased from Dec. 2023 (MXN326 Mil) to Dec. 2024 (MXN413 Mil) and increased from Dec. 2024 (MXN413 Mil) to Dec. 2025 (MXN1,350 Mil).

Insulet Accounts Payable Historical Data

* Premium members only.

The historical data trend for Insulet's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Insulet Accounts Payable Chart

Insulet Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 773.38 600.48 325.91 412.94 1,350.43

Insulet Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,178.39 1,809.49 884.19 1,350.43 2,701.30
MEX:PODD
75GF Score
Insulet Corp MEX:PODD
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Insulet Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of MXN2,701 Mil mean?
Insulet (MEX:PODD) has a Accounts Payable of MXN2,701 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Insulet and its competitors.
Is Insulet's Accounts Payable too high?
Insulet's current Accounts Payable is MXN2,701 Mil. Overall, Insulet has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Insulet's Accounts Payable compare to GMED and PEN?
Insulet's Accounts Payable of MXN2,701 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Insulet and its competitors. Insulet's current Accounts Payable is MXN2,701 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Insulet stock overvalued right now?
Based on GuruFocus' analysis, Insulet (MEX:PODD) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN8,194.79, compared to a current price of MXN2,780.00 — trading 66.1% below its estimated fair value. The current Accounts Payable is MXN2,701 Mil. Insulet's overall GF Score™ is 75/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Insulet (MEX:PODD), the current Accounts Payable is MXN2,701 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Insulet (MEX:PODD) Overvalued in 2026?

Based on GuruFocus' analysis, Insulet stock appears to be undervalued. The current stock price of MXN2,780.00 is trading 66.1% below its estimated GF Value™ of MXN8,194.79. GuruFocus considers Insulet to be Significantly Undervalued.

Key valuation signals for MEX:PODD:

  • Accounts Payable: MXN2,701 Mil
  • GF Value™: MXN8,194.79 vs. price of MXN2,780.00 (66.1% below fair value)
  • GF Score™: 75/100

No single metric tells the full story. See the MEX:PODD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Insulet Business Description

Address 100 Nagog Park, Acton, MA, USA, 01720
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
75GF Score

Get the complete analysis for MEX:PODD

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,780.00
Price
MXN8,194.79
GF Value